News | July 28, 2010

Medicare Radiopharmaceutical Coding, Payment Policy Corrected

July 28, 2010 – The Council on Radionuclides and Radiopharmaceuticals (CORAR) applauded a recent decision by a Medicare administrative to correct coding, coverage and payment policies for radiopharmaceuticals used with myocardial perfusion imaging procedures.

The contractor, Trailblazer Health Enterprises LLC, updated language regarding billing for technetium diagnostic radiopharmaceuticals (A9500) and (A9502) used in multiple myocardial perfusion imaging studies (CPT 78452), which incorrectly limited payment to one dose.

“For the past several years, CORAR members and the Society of Nuclear Medicine (SNM), the American College of Radiology (ACR), the American College of Cardiology (ACC), and the American Society of Nuclear Cardiology (ASNC) have requested that Trailblazer adjust its policy so that providers may bill and be appropriately reimbursed when two technetium heart agent radiopharmaceutical doses are administered consistent with appropriate clinical practice guidelines,” said Michael Guastella, current chairman of the CORAR Healthcare Policy Committee for Reimbursement.

Guastella said the policy in question was inconsistent with good clinical practice and hospital and pharmacy standards. CORAR worked with the medical specialty societies to bring this issue to the attention of CMS. In a letter dated May 21, CORAR brought this issue to the attention of the deputy regional administrator for the Dallas Regional Office of the Centers for Medicare and Medicaid Services (CMS). In response, CMS’s Division of Financial Management and Fee for Service Operations, Region VI consulted with clinical and policy staff at the CMS Central Office and contacted Trailblazer’s medical director. In response to CORAR’s letter the CMS Regional Office communicated that Trailblazer would be withdrawing the language regarding billing for more than one unit of technetium heart agent radiopharmaceutical (A9500) and (A9502) and no longer limit billing to a single dose.

“We believe that this change will allow providers to bill appropriately for the diagnostic radiopharmaceuticals administered while being consistent with Medicare HCPCS coding guidelines, clinical standards and product labeling standards.” said Gail Daubert of ReedSmith, legal counsel to CORAR.

CORAR is an industry trade association comprised of North American manufacturers, developers and suppliers of radiopharmaceuticals and radionuclides primarily used in nuclear medicine and life science research.

Related Content

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...
A 3-D printed tungsten X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | April 29, 2019 | By Steve Jeffery
In ...
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...